Anavex
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Anavex and other ETFs, options, and stocks.About AVXL
Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome.
CEOChristopher U. Missling
CEOChristopher U. Missling
Employees42
Employees42
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2004
Founded2004
Employees42
Employees42
AVXL Key Statistics
Market cap808.26M
Market cap808.26M
Price-Earnings ratio-16.59
Price-Earnings ratio-16.59
Dividend yield—
Dividend yield—
Average volume913.53K
Average volume913.53K
High today$9.51
High today$9.51
Low today$9.18
Low today$9.18
Open price$9.45
Open price$9.45
Volume696.49K
Volume696.49K
52 Week high$14.44
52 Week high$14.44
52 Week low$4.93
52 Week low$4.93
AVXL News
TipRanks 7d
Anavex Life Sciences Earnings Call: Promising Alzheimer’s Progress Amid Operational ChallengesAnavex Life Sciences ((AVXL)) has held its Q3 earnings call. Read on for the main highlights of the call. Elevate Your Investing Strategy: Take advantage of Tip...
People also own
Based on the portfolios of people who own AVXL. This list is generated using Robinhood data, and it’s not a recommendation.